Macleods Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MACLEODS PHARMS LTD
MACLEODS PHARMS LTD has twenty approved drugs.
There are thirteen tentative approvals on MACLEODS PHARMS LTD drugs.
Summary for Macleods Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 18 |
| Ingredients: | 18 |
| NDAs: | 20 |
Drugs and US Patents for Macleods Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macleods Pharms Ltd | IRBESARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; irbesartan | TABLET;ORAL | 202414-002 | Sep 27, 2012 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Macleods Pharms Ltd | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | TABLET;ORAL | 217949-001 | Sep 23, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Macleods Pharms Ltd | VALSARTAN AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; valsartan | TABLET;ORAL | 203145-001 | Apr 19, 2013 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
